Our study found a number of novel associations between blood DNAm and CSF Aβ42, phosphorylated tau181, and total tau, which are proxy biomarkers of AD pathophysiology, demonstrating that changes in various pathological processes in the CSF are reflected in the blood epigenome. This evidence concerns the gene MAPT and Alzheimer disease.